Welcome to our dedicated page for RYMDF news (Ticker: RYMDF), a resource for investors and traders seeking the latest updates and insights on RYMDF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RYMDF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RYMDF's position in the market.
Scryb Inc. (OTCQB: RYMDF) announced the appointment of Duncan Sparrell and Setu Kulkarni to the Cybeats strategic advisory board. Their expertise aims to enhance the company's commercial strategy in cybersecurity. Sparrell, former Chief Security Architect at AT&T, brings over 40 years of experience, while Kulkarni has a strong background in corporate strategy and product management from Venafi and WhiteHat Security. CEO Yoav Raiter expressed confidence that these appointments will drive Cybeats' growth in 2022 as the company seeks to expand its platform.
Scryb Inc. (CSE: SCYB, OTCQB: RYMDF) announced the appointment of Leon Rosenzwaig as the new Vice President of Product Management. Rosenzwaig has over 25 years of experience in product management and is well-known for launching innovative products in consumer electronics, such as the first Android phone in Canada. His role is crucial as Scryb focuses on enhancing its product lines and driving commercial success during an important transitional phase. CEO Yoav Raiter emphasized the significance of this appointment for the company's renewed strategic direction.
Scryb Inc. has commenced trading on the CSE under the ticker symbol SCYB as of December 9, 2021. The name 'Scryb' combines elements of prediction and documentation, reflecting the company’s commitment to applied intelligence and analytics. CEO Yoav Raiter expressed gratitude to shareholders for their support and emphasized the company’s vision for growth. Scryb's platform incorporates IoT, predictive analytics, and sensor technology, targeting diverse industries including digital health and cybersecurity. For updates, visit www.scryb.ai.
Relay Medical Corp. (RYMDF) highlighted a critical cybersecurity vulnerability in Hikvision's surveillance cameras impacting over 100 million connected devices. Hikvision, which controls approximately 40% of the global market, has a vulnerability score of 9.8, signifying a major risk. Companies like Toshiba, Honeywell, and Panasonic are affected, as Hikvision components are often rebranded. Cybeats offers solutions to fortify device security, advocating for Software Bills of Materials (SBoM) to manage vulnerabilities effectively. The rise of IoT cyber attacks, reported by Kaspersky to have doubled in 2021, reinforces the urgency of addressing such vulnerabilities.
Relay Medical Corp. has signed a definitive agreement with the Rwanda Ministry of Health to deploy the Fionet Platform for decentralized malaria testing. This initiative, part of the Fionet Rapid Response Group joint venture, will receive CAD $750,000 for a six-month pilot involving 180 healthcare workers. Successful deployment could scale up to include 60,000 workers. Fionet aims to enhance healthcare quality through real-time data transmission, previously demonstrated in COVID-19 testing. Relay Medical is focused on innovative healthcare solutions.
Relay Medical Corp. (OTCQB: RYMDF) recently hosted a webinar titled “State of Cybersecurity Industry - The Roots of SBoM,” featuring experts discussing key cybersecurity challenges and the Biden Administration’s Executive Order on Nationwide Cybersecurity. The panel included industry leaders such as Kate Stewart and Steve Springett, who addressed the importance of Software Bills of Materials (SBoMs) in enhancing software transparency and vulnerability management. The webinar highlighted the potential for SBoM adoption in various sectors, including healthcare, to mitigate risks and enhance cybersecurity practices.
Relay Medical Corp. and Fio Corporation have partnered with Unisys Corporation to market a joint solution featuring FRR’s Fionet Platform, which addresses the biosecurity market. This integrated platform combines mobile testing and digital health management systems, aiming to simplify biosecurity for various sectors, including large enterprises and government agencies. The COVID-19 diagnostic market is projected to exceed USD $84 billion, indicating significant growth potential. The partnership aims to leverage Unisys' IT expertise and Relay's technology for enhanced market penetration.
Relay Medical Corp. and Fio Corporation have reached an agreement with Rwanda's Ministry of Health to deploy the Fionet Platform for malaria containment, with initial funding of over CAD $750,000 for a six-month pilot. Successful implementation may lead to a nationwide rollout. The Fionet Platform, effective in various health crises like COVID-19, provides real-time data collection and actionable insights for healthcare systems. Additionally, Relay granted options to purchase 500,000 shares at $0.25 each, expiring in five years.
Relay Medical Corp. (RYMDF) has launched a new home and small business testing system leveraging its Pharmatrac platform and FRR’s Fionet technology. This affordable testing solution, retailing under $150 CAD, is designed for rapid COVID-19 antigen and antibody tests, enhancing compliance and testing quality. The platform promotes self-screening through a mobile app, and features machine vision and AI capabilities for accurate results. With ongoing partnerships and product development, Relay is positioned to meet the growing demand for efficient COVID-19 testing in various community settings.
Relay Medical Corp has partnered with Fio Corporation through their joint venture, Fionet Rapid Response Group, to implement the Fionet Platform for rapid COVID-19 testing at the 2021 National Bank Open tennis tournament in Toronto, running from August 7-15. LifeLabs, a leading diagnostic provider, will oversee the testing, which begins on July 31. The Fionet Platform offers fast and quality-controlled testing with real-time results, ensuring safety for participants and attendees at this prestigious event featuring top ATP players.
